The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Abiomed Inc. (NSDQ:ABMD) absolutely crushed it during the first quarter, riding the momentum of its Impella heart pump to a 51.2 percent increase in its share price.
The Danvers, Mass.-based company closed 2010 at $9.61 per share. It opened this year up 1.1 percent, at $9.72, and proceeded to go on a tear for the next three months. ABMD stock hit a high-water mark of $14.91 March 30, averaged $12.32 during the quarter and closed the three months ended March 31 at $14.53.
ReGen Biologics Inc. (PINK:RGBO) doesn’t have enough money to pay for its annual earnings filing with the Securities & Exchange Commission.
China Kanghui Holdings (NYSE:KH), a Chinese orthopedic implant maker that went public on the New York Stock Exchange last year, bought out a majority stake of a fellow Chinese implant maker, a move China Kanghui said will make it a player in both the Chinese and international markets by 2014.
The Changzhou, China-based device company said in a regulatory filing that it picked up a 60 percent interest in Beijing Wei Rui Li Medical Device Co. Ltd., a maker of hip and knee systems.
Shares of St. Jude Medical Inc. (NYSE:STJ) hit a 52-week high in mid-day trading on Wall Street today, with investors basking in the glow of a bullish recommendation from a JP Morgan analyst on the company’s new Quadra implantable defibrillator system.
In a note to investors, Michael Weinstein, a J.P. Morgan analyst, called the device “the most important new product” in implantable defibrillators in the last nine years.
BlackRock Inc. (NYSE:BLK) increased stake in British orthopedic device maker Smith & Nephew plc (NYSE:SNN) by some 2 million shares, making it the company’s single largest investor.
BlackRock, which previously owned 42 million shares of SNN stock, acquired nearly 3 million additional shares, according to regulatory filings.
Covidien plc (NYSE:COV) will take its Solitaire FR revascularization device directly to regulators rather than wait for additional clinical data, after an independent panel’s review of the data collected so far.
Xoft Inc. could turn out to be a lot more expensive for iCad (NSDQ:ICAD) than the $1 million in cash and the 8.47 million shares of stock it paid for the oncology device manufacturer late last year.
Fresenius Medical Care AG (NYSE:FMS) shares are rebounding from earlier losses and were back to within 50 cents of even for today’s session at $68.14 each, after the German medical device manufacturer announced plans to acquire the Crit-Line system from privately held Hema Metrics. Terms of the deal were not immediately available.
Boston Scientific Corp. (NYSE:BSX) co-founder John Abele will not stand for re-election to the company’s board when his current term expires in May. Two other long-time board members — Marye Anne Fox and Ray Groves — also plan to step down.
Buoyed by strong growth in the vision-care unit during its latest reporting period, The Cooper Companies Inc. (NYSE:COO) last night raised its earnings and revenue forecast for the rest of the year, sending the company’s stock on a tear when trading began this morning.
Executives at NeuroMetrix Inc. (NSDQ:NURO) don’t appear to be in any rush to take on any new debt, but they could borrow up to $7.5 million after signing a one-year extension of a revolving credit facility with Comerica Bank.
